Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Equinix $1.5 billion at-the-market offering
We advised the company on the SEC-registered at-the-market offering
Walgreens $2.25 billion Summit Health-CityMD acquisition financing
We are advising the lender in connection with the facilities
Neovia Logistics recapitalization
We advised Neovia Logistics in connection with its recapitalization
Honeywell $2 billion senior notes offering
The investment-grade notes are due 2024, 2028 and 2033
Honeywell €1 billion senior notes offering
The investment-grade notes are due 2034
TIAA sale of TIAA Bank
We are advising TIAA on the transaction
NextGen Healthcare $275 million convertible senior notes offering
The 3.75% convertible notes are due 2027
Emerson $14 billion sale of Climate Technologies to Blackstone
We are advising Emerson on the transaction
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Verisk $3.1 billion sale of Wood Mackenzie to Veritas Capital
We are advising Verisk on the transaction